ArticleChemistry & biodiversity2026
Integrated Approach for the Discovery of Antifungal and Antibiofilm Agents From Cerrado Plants.
Article in Chemistry & biodiversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
The increasing incidence of Candida albicans infections, especially those involving drug-resistant strains, highlights the need for new antifungal agents. In this study, 108 plant extracts from native and endemic species of the Brazilian Cerrado were screened against C. albicans in both planktonic and biofilm forms (developing and mature). Eighteen extracts demonstrated significant antifungal and antibiofilm activity, particularly from species in the Fabaceae, Myrtaceae, and Celastraceae families. Extracts from Hymenaea stigonocarpa notably inhibited the yeast-to-hyphae transition, a key virulence factor. Using molecular networking (GNPS) and in silico tools (SIRIUS), 60 putative compounds were annotated, including xanthones, flavonoids and triterpenoids, with selected candidates showing favorable binding profiles in molecular docking analyses. This integrative metabolomic approach enabled the identification of bioactive scaffolds, reinforcing the Cerrado biome as a valuable source of structurally diverse metabolites for antifungal drug discovery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.